<?xml version="1.0" encoding="UTF-8"?>
<ref id="R7">
 <label>[7]</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Luen</surname>
    <given-names>SJ</given-names>
   </name>
   <name>
    <surname>Salgado</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Dieci</surname>
    <given-names>MV</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy</article-title>. 
  <source>Ann Oncol Off J Eur Soc Med Oncol</source>
  <year>2019</year>;
  <volume>30</volume>:
  <fpage>236</fpage>â€“
  <lpage>42</lpage>. 
  <comment>doi: 10.1093/annonc/mdy547</comment>.
 </mixed-citation>
</ref>
